trending Market Intelligence /marketintelligence/en/news-insights/trending/7XjP61xmIo-k4VEMsM9pPA2 content esgSubNav
In This List

CymaBay CEO to retire; interim named

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


CymaBay CEO to retire; interim named

Harold Van Wart is retiring as CymaBay Therapeutics Inc.'s president and CEO on April 14. He will also not stand for re-election to the board at the upcoming annual meeting of directors.

The company's CFO, Sujal Shah, will take over Wart's duties on an interim basis. Robert Wills will become executive chairman to provide continuity during the transition.